Literature DB >> 9163477

Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay.

K A Crotchfelt1, L E Welsh, D DeBonville, M Rosenstraus, T C Quinn.   

Abstract

A coamplification PCR test for the direct detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urethral and endocervical swabs and urine samples from men and women was compared to standard culture techniques. Processed specimens were amplified in single reaction tubes containing primers for both organisms, and PCR products were detected by a colorimetric microwell plate hybridization assay specific for each pathogen. Of 344 specimens from men, 45 (13.1%) urine specimens were PCR positive for C. trachomatis, 51 (14.8%) urethral swab specimens were PCR positive, and 29 urethral swab specimens (8.4%) were culture positive. After analysis of discrepancies, the resolved sensitivity and specificity of PCR for C. trachomatis were 96.2 and 99.3%, respectively, in urethral swab specimens, compared to 88.2 and 98.6% for urine specimens. Of the 192 specimens from women, 28 (14.6%) urine specimens were PCR positive for C. trachomatis, 32 (16.7%) endocervical specimens were PCR positive, and 19 (9.9%) endocervical specimens were culture positive. After analysis of discrepancies, the resolved sensitivity and specificity of PCR for C. trachomatis for endocervical specimens were both 100% compared to 100 and 99.4%, respectively, for urine specimens from women. In men, 68 (19.8%) urine specimens were PCR positive for N. gonorrhoeae, 73 (21.2%) urethral swabs were PCR positive, and 59 (17.2%) urethral swabs were culture positive. After analysis of discrepancies, the resolved sensitivity and specificity of PCR for N. gonorrhoeae were 97.3 and 97.0%, respectively, for urethral specimens compared to 94.4 and 98.5% for urine specimens. In women, 18 (9.4%) urine specimens were PCR positive for N. gonorrhoeae, 23 (12.0%) were endocervical swab PCR positive, and 15 (7.8%) endocervical specimens were culture positive. After analysis of discrepancies, the resolved sensitivity and specificity of PCR for N. gonorrhoeae were 100 and 99.4%, respectively, for endocervical specimens compared to 90.0 and 95.9% for female urine specimens. These results indicate that a multiplex PCR is highly sensitive for detecting both C. trachomatis and N. gonorrhoeae from a single urine or genital swab, providing a more cost-effective way of screening multiple pathogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163477      PMCID: PMC229782          DOI: 10.1128/jcm.35.6.1536-1540.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens.

Authors:  J B Mahony; M A Chernesky
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

2.  Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys.

Authors:  M A Shafer; V Prager; J Shalwitz; E Vaughan; B Moscicki; R Brown; C Wibbelsman; J Schachter
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

3.  Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.

Authors:  K R Smith; S Ching; H Lee; Y Ohhashi; H Y Hu; H C Fisher; E W Hook
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.

Authors:  S Ching; H Lee; E W Hook; M R Jacobs; J Zenilman
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 5.  Recent advances in diagnosis of sexually transmitted diseases.

Authors:  T C Quinn
Journal:  Sex Transm Dis       Date:  1994 Mar-Apr       Impact factor: 2.830

6.  Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction.

Authors:  M A Chernesky; D Jang; H Lee; J D Burczak; H Hu; J Sellors; S J Tomazic-Allen; J B Mahony
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

Review 7.  Diagnosis of Chlamydia trachomatis genitourinary infections.

Authors:  W E Stamm
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

8.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

9.  Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies.

Authors:  W E Stamm; M Tam; M Koester; L Cles
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

10.  Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine.

Authors:  J E Bauwens; A M Clark; M J Loeffelholz; S A Herman; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

View more
  35 in total

1.  Evaluation of the NucliSens Basic Kit for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genital tract specimens using nucleic acid sequence-based amplification of 16S rRNA.

Authors:  J B Mahony; X Song; S Chong; M Faught; T Salonga; J Kapala
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Comparison of urine, first and second endourethral swabs for PCR based detection of genital Chlamydia trachomatis infection in male patients.

Authors:  H Sugunendran; H D Birley; H Mallinson; M Abbott; C Y Tong
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

3.  Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens.

Authors:  C H Livengood; J W Wrenn
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 4.  The role of DNA amplification technology in the diagnosis of infectious diseases.

Authors:  M Louie; L Louie; A E Simor
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

5.  Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG test for diagnosis of Neisseria gonorrhoeae infection in a low-prevalence population.

Authors:  David J Diemert; Michael D Libman; Pierre Lebel
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens.

Authors:  Lisa A Cosentino; Daniel V Landers; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

7.  Performance of the MagNA pure LC robot for extraction of Chlamydia trachomatis and Neisseria gonorrhoeae DNA from urine and swab specimens.

Authors:  Nicholas Dalesio; Vince Marsiglia; Andrew Quinn; Thomas C Quinn; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests.

Authors:  E Van Dyck; M Ieven; S Pattyn; L Van Damme; M Laga
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

9.  Comparison of COBAS AMPLICOR Neisseria gonorrhoeae PCR, including confirmation with N. gonorrhoeae-specific 16S rRNA PCR, with traditional culture.

Authors:  Dirk S Luijt; Petra A J Bos; Anton A van Zwet; Pieter C van Voorst Vader; Jurjen Schirm
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.

Authors:  Charlotte A Gaydos; Mellisa Theodore; Nicholas Dalesio; Billie Jo Wood; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.